Announcement from FRISQ’s extra general meeting

The extra general meeting in Frisq Holding AB (publ) (”FRISQ” or the ”Company”) was held today on 30 January 2020 and the following resolutions were passed by the meeting.

Approval of rights issue

The extra general meeting resolved, in accordance with the board of directors’ proposal, to approve the preferential rights issue of a maximum of 7,175,460 shares which had previously been resolved upon by the board of directors. Through the rights issue, the Company’s share capital can increase by a maximum of SEK 358,773.00 to a total of SEK 1,554,683.10, and the number of shares can increase by a maximum of 7,175,460 shares to 31,093,662 shares. The subscription price for the shares is SEK 9.00 per share. The rights issue can provide the Company with proceeds amounting to a total of approximately SEK 64.6 million. Subscription of shares with subscription rights shall be made during the period from 4 February 2020 up to and including 18 February 2020 and paid in cash.

Further information about the rights issue will be available in the prospectus to be published following the Swedish Financial Supervisory Authority’s approval.

Authorisation for the board of directors to issue shares

The extra general meeting resolved, in accordance with the board of directors’ proposal, to authorise the board of directors, up until the next annual general meeting, at one or several occasions and with deviation from the shareholders’ preferential rights, to resolve on new share issues within the limits of the articles of association to be paid by way of set of.
The purpose with the authorisation and the reason for the deviation from the shareholders’ preferential rights is to enable a new share issue to the guarantors in the rights issue who choose to receive their compensation in FRISQ shares.
For further information regarding the above resolutions, please refer to the proposals set out in the notice to the extra general meeting, the board of directors’ complete proposals and the press release regarding the rights issue which are available at the Company’s website, www.frisqholding.se.

For further information, please contact:

Martin Irding, CEO FRISQ
Tel: +46 (0)8 120 131 21
martin.irding@frisq.se

About FRISQ

The health-tech company FRISQ develops scalable digital tools for interactive communication between the players in the healthcare sphere.
FRISQ is listed on Nasdaq First North Growth Market in Stockholm since 2016 under the ticker ”FRISQ”.
FNCA Sweden AB is FRISQ’s Certified Adviser. Tel +46 (0)8 528 00 399, info@fnca.se

For further information, please visit www.frisqholding.se